Agenda

Agenda

The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field, including emerging concepts and therapies in GI, rare tumors, cancers affecting the gastrointestinal tract, and much more.

All Industry supported CME educational sessions will be available at no cost. Learners can access this material via the HMP Education Network. Learn more here.

March 22-23 | New York City

March 22-23 | New York City

- Co-Chair
  - Cathy Eng MD, FACP, FASCO
  - Yelena Janjigian MD
- Presenter
  - Ryan Moy MD, PhD
- Presenter
  - Michael Gibson MD, PhD
- Panelist
  - Michael Gibson MD, PhD
  - Ryan Moy MD, PhD
- Presenter
  - Lakshmi Rajdev MD, MS
- Presenter
  - Nataliya Uboha MD, PhD
- Panelist
  - Lakshmi Rajdev MD, MS
  - Nataliya Uboha MD, PhD
Establishing a Treatment Paradigm in Metastatic Pancreatic Cancer Speaker: Farshid Dayyani, MD, PhD, University of California Irvine
- Presenter
  - Thomas Cartwright MD
HMP Education would like to acknowledge the following grant support for Great Debates & Updates in Gastrointestinal Malignancies: Agenus Inc., Astellas, AstraZeneca, Daiichi Sankyo, Inc., Incyte Corporation, and Servier Pharmaceuticals LLC.
- Presenter
  - Maheswari Senthil MD
- Presenter
  - Nataliya Uboha MD, PhD
- Panelist
  - Maheswari Senthil MD
  - Nataliya Uboha MD, PhD
Clinical Management of HCC With CABOMETYX (cabozantinib) Speaker: Amit Mahipal, MD, MPH
- Presenter
  - Thomas Cartwright MD
HMP Education would like to acknowledge the following grant support for Great Debates & Updates in Gastrointestinal Malignancies: Agenus Inc., Astellas, AstraZeneca, Daiichi Sankyo, Inc., Incyte Corporation, and Servier Pharmaceuticals LLC.
- Presenter
  - Heather Hampel MS, CGC
- Presenter
  - Michael Hall MD, MS
- Panelist
  - Heather Hampel MS, CGC
  - Michael Hall MD, MS
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer Speaker: Putao Cen, MD
- Presenter
  - Midhun Malla MD, MS
HMP Education would like to acknowledge the following grant support for Great Debates & Updates in Gastrointestinal Malignancies: Agenus Inc., Astellas, AstraZeneca, Daiichi Sankyo, Inc., Incyte Corporation, and Servier Pharmaceuticals LLC.
- Presenter
  - Kristen Ciombor MD, MSCI
- Presenter
  - Smitha Krishnamurthi MD
- Panelist
  - Kristen Ciombor MD, MSCI
  - Smitha Krishnamurthi MD

- Co-Chair
  - Cathy Eng MD, FACP, FASCO
  - Yelena Janjigian MD
- Presenter
  - Andrew Marsala MD
- Presenter
  - Armeen Mahvash MD
- Panelist
  - Andrew Marsala MD
  - Armeen Mahvash MD
- Presenter
  - Rachna Shroff MD, MS, FASCO
- Presenter
  - Milind Javle MD
- Panelist
  - Milind Javle MD
  - Rachna Shroff MD, MS, FASCO
A Treatment Option for Certain Adults With Advanced Gastric or GEJ Adenocarcinoma Speaker: Ronan Kelly, MD
- Presenter
  - Ghassan Abou-Alfa MD, MBA
HMP Education would like to acknowledge the following grant support for Great Debates & Updates in Gastrointestinal Malignancies: Agenus Inc., Astellas, AstraZeneca, Daiichi Sankyo, Inc., Incyte Corporation, and Servier Pharmaceuticals LLC.
- Presenter
  - Adam Yopp MD
- Presenter
  - Sekhar Padmanabhan MD
- Panelist
  - Adam Yopp MD
  - Sekhar Padmanabhan MD
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade Speaker: Maen Abdelrahim, MD, PhD, PharmB
- Presenter
  - Syed Kazmi MD
HMP Education would like to acknowledge the following grant support for Great Debates & Updates in Gastrointestinal Malignancies: Agenus Inc., Astellas, AstraZeneca, Daiichi Sankyo, Inc., Incyte Corporation, and Servier Pharmaceuticals LLC.
- Presenter
  - Arvind Dasari MD
- Presenter
  - Jason Zell DO, MPH
- Panelist
  - Arvind Dasari MD
  - Jason Zell DO, MPH
- Presenter
  - Prajnan Das MD, MS, MPH, FACR, FASTRO
- Presenter
  - Natalie Lockney MD
- Panelist
  - Natalie Lockney MD
  - Prajnan Das MD, MS, MPH, FACR, FASTRO
- Presenter
  - Hagen Kennecke MD, MHA, FRCPC
- Presenter
  - Ardaman Shergill MD, MSPH
- Panelist
  - Ardaman Shergill MD, MSPH
  - Hagen Kennecke MD, MHA, FRCPC

Highlights

Colorectal Cancers

Gastroesophageal Cancer

Gastrointestinal Cancer: Emerging Concepts & Therapies

Hepatobiliary Cancers

Pancreatic Cancer

Rare Tumors

Targeted Approaches in Gastric Cancers and Other GI Malignancies